ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Income Statement History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹2,282 Cr | ₹1,723 Cr | ₹1,302 Cr | ₹1,008 Cr | ₹809 Cr |
| Sales | ₹2,162 Cr | ₹1,615 Cr | ₹1,212 Cr | ₹946 Cr | ₹765 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | ₹117 Cr | ₹105 Cr | ₹90 Cr | ₹61 Cr | ₹44 Cr |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | ₹3.00 Cr | ₹3.00 Cr | - | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹2,276 Cr | ₹1,716 Cr | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | ₹-488 Cr | ₹-333 Cr | ₹-34 Cr | ₹-49 Cr | ₹14 Cr |
| Raw Material Consumed | ₹1,869 Cr | ₹1,291 Cr | ₹624 Cr | ₹404 Cr | ₹291 Cr |
| Opening Raw Materials | ₹8.98 Cr | ₹18 Cr | ₹15 Cr | ₹14 Cr | ₹20 Cr |
| Purchases Raw Materials | ₹0.51 Cr | ₹273 Cr | ₹128 Cr | ₹81 Cr | ₹77 Cr |
| Closing Raw Materials | - | ₹8.98 Cr | ₹18 Cr | ₹15 Cr | ₹14 Cr |
| Other Direct Purchases / Brought in cost | ₹1,859 Cr | ₹1,009 Cr | ₹499 Cr | ₹324 Cr | ₹208 Cr |
| Other raw material cost | - | - | - | - | - |
| Power & Fuel Cost | ₹2.88 Cr | ₹5.30 Cr | ₹4.87 Cr | ₹5.54 Cr | ₹8.10 Cr |
| Electricity & Power | ₹2.88 Cr | ₹5.30 Cr | ₹4.87 Cr | ₹5.54 Cr | ₹8.10 Cr |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹264 Cr | ₹257 Cr | ₹241 Cr | ₹259 Cr | ₹230 Cr |
| Salaries, Wages & Bonus | ₹223 Cr | ₹224 Cr | ₹204 Cr | ₹225 Cr | ₹199 Cr |
| Contributions to EPF & Pension Funds | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹11 Cr | ₹11 Cr |
| Workmen and Staff Welfare Expenses | ₹17 Cr | ₹14 Cr | ₹20 Cr | ₹16 Cr | ₹13 Cr |
| Other Employees Cost | ₹13 Cr | ₹7.72 Cr | ₹7.02 Cr | ₹7.15 Cr | ₹6.49 Cr |
| Other Manufacturing Expenses | ₹112 Cr | ₹49 Cr | ₹89 Cr | ₹76 Cr | ₹57 Cr |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | ₹4.08 Cr | ₹5.78 Cr | ₹6.23 Cr | ₹6.00 Cr | ₹4.94 Cr |
| Packing Material Consumed | - | ₹5.22 Cr | ₹4.53 Cr | ₹4.76 Cr | ₹6.68 Cr |
| Other Mfg Exp | ₹108 Cr | ₹38 Cr | ₹79 Cr | ₹65 Cr | ₹46 Cr |
| General and Administration Expenses | ₹81 Cr | ₹75 Cr | ₹66 Cr | ₹57 Cr | ₹40 Cr |
| Rent , Rates & Taxes | ₹2.67 Cr | ₹8.86 Cr | ₹3.22 Cr | ₹2.35 Cr | ₹2.01 Cr |
| Insurance | ₹6.89 Cr | ₹4.11 Cr | ₹3.87 Cr | ₹2.95 Cr | ₹2.70 Cr |
| Printing and stationery | - | - | - | - | - |
| Professional and legal fees | ₹44 Cr | ₹43 Cr | ₹35 Cr | ₹23 Cr | ₹21 Cr |
| Traveling and conveyance | ₹24 Cr | ₹16 Cr | ₹21 Cr | ₹24 Cr | ₹10 Cr |
| Other Administration | ₹4.54 Cr | ₹4.26 Cr | ₹3.60 Cr | ₹3.59 Cr | ₹3.82 Cr |
| Selling and Distribution Expenses | ₹140 Cr | ₹104 Cr | ₹97 Cr | ₹72 Cr | ₹62 Cr |
| Advertisement & Sales Promotion | - | - | - | - | - |
| Sales Commissions & Incentives | - | - | - | - | ₹5.10 Cr |
| Freight and Forwarding | ₹24 Cr | ₹19 Cr | ₹11 Cr | ₹12 Cr | ₹6.27 Cr |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | ₹116 Cr | ₹85 Cr | ₹86 Cr | ₹60 Cr | ₹51 Cr |
| Miscellaneous Expenses | ₹32 Cr | ₹14 Cr | ₹21 Cr | ₹14 Cr | ₹17 Cr |
| Bad debts /advances written off | ₹0.90 Cr | - | - | ₹0.03 Cr | ₹0.29 Cr |
| Provision for doubtful debts | ₹17 Cr | ₹0.66 Cr | ₹5.44 Cr | ₹1.67 Cr | ₹4.00 Cr |
| Losson disposal of fixed assets(net) | - | - | - | - | - |
| Losson foreign exchange fluctuations | - | ₹0.37 Cr | ₹0.50 Cr | - | ₹0.13 Cr |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹14 Cr | ₹13 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹2,014 Cr | ₹1,462 Cr | ₹1,111 Cr | ₹838 Cr | ₹719 Cr |
| Operating Profit (Excl OI) | ₹262 Cr | ₹254 Cr | ₹184 Cr | ₹165 Cr | ₹86 Cr |
| Other Income | ₹28 Cr | ₹41 Cr | ₹35 Cr | ₹26 Cr | ₹15 Cr |
| Interest Received | ₹23 Cr | ₹32 Cr | ₹33 Cr | ₹23 Cr | ₹11 Cr |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | ₹0.16 Cr | ₹0.32 Cr | ₹0.03 Cr | ₹2.49 Cr | ₹2.82 Cr |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | ₹0.18 Cr | - | - |
| Foreign Exchange Gains | ₹0.11 Cr | - | - | ₹0.28 Cr | - |
| Others | ₹5.02 Cr | ₹8.75 Cr | ₹2.02 Cr | ₹0.21 Cr | ₹0.46 Cr |
| Operating Profit | ₹291 Cr | ₹295 Cr | ₹219 Cr | ₹191 Cr | ₹101 Cr |
| Interest | ₹4.49 Cr | ₹1.46 Cr | ₹1.20 Cr | ₹0.63 Cr | ₹0.95 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | - | - | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | - | - | - | - | - |
| Other Interest | ₹4.49 Cr | ₹1.46 Cr | ₹1.20 Cr | ₹0.63 Cr | ₹0.95 Cr |
| PBDT | ₹286 Cr | ₹293 Cr | ₹218 Cr | ₹191 Cr | ₹100 Cr |
| Depreciation | ₹29 Cr | ₹40 Cr | ₹15 Cr | ₹16 Cr | ₹17 Cr |
| Profit Before Taxation & Exceptional Items | ₹257 Cr | ₹253 Cr | ₹203 Cr | ₹174 Cr | ₹83 Cr |
| Exceptional Income / Expenses | ₹-5.25 Cr | ₹-97 Cr | ₹16 Cr | ₹-40 Cr | - |
| Profit Before Tax | ₹252 Cr | ₹156 Cr | ₹220 Cr | ₹134 Cr | ₹83 Cr |
| Provision for Tax | ₹65 Cr | ₹41 Cr | ₹58 Cr | ₹35 Cr | ₹21 Cr |
| Current Income Tax | ₹59 Cr | ₹60 Cr | ₹54 Cr | ₹38 Cr | ₹23 Cr |
| Deferred Tax | ₹5.26 Cr | ₹-20 Cr | ₹-0.90 Cr | ₹-3.49 Cr | ₹-1.19 Cr |
| Other taxes | ₹0.28 Cr | ₹0.44 Cr | ₹5.38 Cr | - | - |
| Profit After Tax | ₹188 Cr | ₹116 Cr | ₹162 Cr | ₹99 Cr | ₹62 Cr |
| Extra items | - | - | - | - | - |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹633 Cr | ₹578 Cr | ₹456 Cr | ₹379 Cr | ₹324 Cr |
| Appropriations | ₹820 Cr | ₹694 Cr | ₹617 Cr | ₹478 Cr | ₹386 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | ₹84 Cr | ₹61 Cr | ₹39 Cr | ₹23 Cr | ₹1.74 Cr |
| Equity Dividend % | ₹1,800.00 | ₹1,600.00 | ₹1,200.00 | ₹800.00 | ₹500.00 |
| Earnings Per Share | ₹75.01 | ₹46.30 | ₹64.60 | ₹39.72 | ₹24.64 |
| Adjusted EPS | ₹75.01 | ₹46.30 | ₹64.60 | ₹39.72 | ₹24.64 |
Compare Income Statement of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹20,082.6 Cr | -1.8% | -3.8% | -12.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | 0.5% | 6.8% | 16.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.6% | 8.7% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.4% | 13.8% | 46.9% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -0.4% | 5.8% | -2.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -1.9% | -5.1% | -2.2% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -1.8% |
-3.8% |
-12.2% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses